Last reviewed · How we verify

NCT04526392: KOF

Pubertal Evolutionary Profile of Children Monitored for Fetal Ovarian Cyst

Status unknown Last updated 25 August 2020
What this trial tests

trial testing Questionnaire in Fetal Ovarian Cyst in 83 participants. Status unknown.

Timeline
6 April 2020
Primary endpoint
15 April 2023
30 July 2023

Quick facts

Lead sponsorUniversity Hospital, Toulouse
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment83
Start date6 April 2020
Primary completion15 April 2023
Estimated completion30 July 2023
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Toulouse

Who can join

Adults 8 to 18, female only, with Fetal Ovarian Cyst. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is based on pubertal surveillance of fetal ovarian cysts (KOF). Fetal ovarian cysts (KOF) detected during fetal ultrasound examinations occur during the 3rd trimester of pregnancy and are of unknown cause.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Questionnaire

Trials testing the same drug.

Other University Hospital, Toulouse trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04526392.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing